Evidence map›Paper›PMID 31993556›Full record

ArticleNature metabolism2020

mTORC1 directly inhibits AMPK to promote cell proliferation under nutrient stress.

Naomi X Y Ling, Adrian Kaczmarek, Ashfaqul Hoque, Elizabeth Davie, Kevin R W Ngoei, Kaitlin R Morrison, William J Smiles, Gabriella M Forte, Tingting Wang, Shervi Lie and 5 more

Open access · greenAbstract read
In one paragraph

Article in Nature metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 107 papers.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 159 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Enhancement of Therapeutic mRNA Translation in Cellular Stress Conditions.International journal of molecular sciences · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Naomi X Y Ling *Metabolic Signalling Laboratory, St Vincent's Institute of Medical Research, School of Medicine, University of Melbourne, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0001-6240-4092
Adrian Kaczmarek *Flinders Centre for Innovation in Cancer, College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
Ashfaqul Hoque *Metabolic Signalling Laboratory, St Vincent's Institute of Medical Research, School of Medicine, University of Melbourne, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0003-2384-2983
Elizabeth Davie *Faculty of Life Sciences, University of Manchester, Manchester, UK.
Kevin R W Ngoei *Protein Chemistry and Metabolism Unit, St Vincent's Institute of Medical Research, School of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
Kaitlin R MorrisonFlinders Centre for Innovation in Cancer, College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
William J SmilesMetabolic Signalling Laboratory, St Vincent's Institute of Medical Research, School of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
Gabriella M ForteFaculty of Life Sciences, University of Manchester, Manchester, UK.
Tingting WangFlinders Centre for Innovation in Cancer, College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
Shervi LieFlinders Centre for Innovation in Cancer, College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
Toby A DiteMetabolic Signalling Laboratory, St Vincent's Institute of Medical Research, School of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
Christopher G LangendorfProtein Chemistry and Metabolism Unit, St Vincent's Institute of Medical Research, School of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
John W ScottProtein Chemistry and Metabolism Unit, St Vincent's Institute of Medical Research, School of Medicine, University of Melbourne, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0002-1896-9798
Jonathan S OakhillMetabolic Signalling Laboratory, St Vincent's Institute of Medical Research, School of Medicine, University of Melbourne, Melbourne, Victoria, Australia. joakhill@svi.edu.au.ORCID http://orcid.org/0000-0002-9475-1440
Janni PetersenFlinders Centre for Innovation in Cancer, College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia. janni.petersen@flinders.edu.au.ORCID http://orcid.org/0000-0003-0729-9335
The University of Melbourne · AUFlinders University · AUUniversity of Manchester · GBSt Vincents Institute of Medical Research · AU

Funding

Cancer Research UK A11178Worldwide Cancer Research 16-0052
6 · The paper itself

Abstract

Central to cellular metabolism and cell proliferation are highly conserved signalling pathways controlled by mammalian target of rapamycin (mTOR) and AMP-activated protein kinase (AMPK)

Indexed as

Stress, PhysiologicalAdenylate KinaseCatalytic DomainCell ProliferationDiabetes Mellitus, Type 2Down-RegulationEnzyme ActivationHumansMechanistic Target of Rapamycin Complex 1NeoplasmsNutrientsPhosphorylationSchizosaccharomycesSchizosaccharomyces pombe ProteinsSignal TransductionAdenylate KinaseMechanistic Target of Rapamycin Complex 1NutrientsSchizosaccharomyces pombe Proteins

Identifiers

PMID31993556
PMCPMC6986917
OpenAlexW3000018643

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.